SCHEMBL11048173

SCHEMBL11048173

CN(C)C1(C)CC1(C(N)=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.46
OPRM1 P35372 8/20 0.40
OPRL1 P41146 8/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
OPRK1 P41145 2/20 0.37
POLB P06746 2/20 0.37
GAA P10253 1/20 0.37
SLC6A2 P23975 1/20 0.35
SLC6A3 Q01959 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ELOVL1 Q9BW60 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11048158 0.86 SLC6A4 (0.44) SLC6A4OPRM1OPRL1MEN1KMT2A
SCHEMBL28487473 0.82 SLC6A4 (0.46) SLC6A4OPRM1OPRL1MEN1KMT2A
SCHEMBL11045957 0.76 OPRM1 (0.49) SLC6A4OPRM1OPRL1MEN1KMT2A
SCHEMBL31560810 0.74 ELOVL1 (0.44) SLC6A4MEN1KMT2APOLBMAPT
SCHEMBL20249699 0.74 ELOVL1 (0.44) SLC6A4MEN1KMT2APOLBMAPT
SCHEMBL6553149 0.72 SLC6A4 (0.46) SLC6A4OPRM1MEN1KMT2APOLB
SCHEMBL28149790 0.72 AKR1C1 (0.46) SLC6A4MEN1KMT2APOLBGAA
SCHEMBL28426673 0.72 AKR1C1 (0.53) MEN1KMT2AHTTNPSR1SMN1; SMN2
SCHEMBL28922129 0.68 KMT2A (0.37) SLC6A4MEN1KMT2APOLBGAA
SCHEMBL16833940 0.68 SLC6A4 (0.44) SLC6A4MEN1KMT2APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4478836-A 1-Aryl 2-aminomethyl cyclopropane carboxyamide (Z) derivatives and their use as useful drugs in the treatment of disturbances of the central nervous system PIERRE FABRE S.A. (FR) 1984-10-23 US disclosed